Abstract Objectives: SSc is a clinically heterogeneous and generalized disease, characterized by thickness of the connective tissue of the skin and internal organs, such as the digestive tract, impairing gastrointestinal (GI) motility. Our aim is to evaluate retrospectively abnormalities of oesophageal motility, gastric emptying, oro-cecal transit time (OCTT) and small intestine bacterial overgrowth (SIBO) in a large cohort of SSc patients. Methods: Ninety-nine SSc patients were included in the study. Forty-two patients underwent oesophageal conventional manometry, 45 performed a [13C]octanoic acid breath test to measure gastric emptying time and all 99 patients performed a lactulose breath test in order to evaluate OCTT and SIBO. Data w...
Objectives To evaluate the severity and evolution of patient-reported gastrointestinal tract (GIT) s...
Objective. Esophageal dysmotility is a common and neglected complication of systemic sclerosis (SSc)...
The gastrointestinal (GI) tract can be involved in up to 90% of patients with systemic sclerosis (SS...
Abstract Objectives: SSc is a clinically heterogeneous and generalized disease, characterized by th...
SSc is a clinically heterogeneous and generalized disease, characterized by thickness of the connect...
Abstract OBJECTIVES: To assess the correlation between delayed oro-cecal transit time (OCTT) and eso...
OBJECTIVES: To assess the correlation between delayed oro-cecal transit time (OCTT) and esophageal ...
BACKGROUND: Studies on gastrointestinal symptoms, dysfunctions, and neurological disorders in sy...
Systemic sclerosis (SSc) is a chronic and generalized disease affecting the connective tissue of the...
Systemic sclerosis (SSc) affects the upper gastrointestinal (GI) system in 90% of patients. High-res...
OBJECTIVE This study assessed whether high-resolution manometry (HRM) with a test meal can detect c...
OBJECTIVES: After the skin, the gastrointestinal tract is the second most common target of systemic ...
Systemic sclerosis (SSc) is a rare systemic, autoimmune disease characterized by vascular changes an...
Objectives. The aims of this study were to: (i) determine the prevalence of small intestinal bacteri...
Introduction/objectives Gastrointestinal tract (GIT) involvement is frequently observed in systemic...
Objectives To evaluate the severity and evolution of patient-reported gastrointestinal tract (GIT) s...
Objective. Esophageal dysmotility is a common and neglected complication of systemic sclerosis (SSc)...
The gastrointestinal (GI) tract can be involved in up to 90% of patients with systemic sclerosis (SS...
Abstract Objectives: SSc is a clinically heterogeneous and generalized disease, characterized by th...
SSc is a clinically heterogeneous and generalized disease, characterized by thickness of the connect...
Abstract OBJECTIVES: To assess the correlation between delayed oro-cecal transit time (OCTT) and eso...
OBJECTIVES: To assess the correlation between delayed oro-cecal transit time (OCTT) and esophageal ...
BACKGROUND: Studies on gastrointestinal symptoms, dysfunctions, and neurological disorders in sy...
Systemic sclerosis (SSc) is a chronic and generalized disease affecting the connective tissue of the...
Systemic sclerosis (SSc) affects the upper gastrointestinal (GI) system in 90% of patients. High-res...
OBJECTIVE This study assessed whether high-resolution manometry (HRM) with a test meal can detect c...
OBJECTIVES: After the skin, the gastrointestinal tract is the second most common target of systemic ...
Systemic sclerosis (SSc) is a rare systemic, autoimmune disease characterized by vascular changes an...
Objectives. The aims of this study were to: (i) determine the prevalence of small intestinal bacteri...
Introduction/objectives Gastrointestinal tract (GIT) involvement is frequently observed in systemic...
Objectives To evaluate the severity and evolution of patient-reported gastrointestinal tract (GIT) s...
Objective. Esophageal dysmotility is a common and neglected complication of systemic sclerosis (SSc)...
The gastrointestinal (GI) tract can be involved in up to 90% of patients with systemic sclerosis (SS...